CHO Pharma, Inc. (TPEX:6586)
Taiwan · Delayed Price · Currency is TWD 110.50
-1.50 (-1.34%)
Aug 26, 2026, 1:54 PM CST
CHO Pharma Revenue
CHO Pharma had revenue of 719.00K TWD in the half year ending December 31, 2025. This brings the company's revenue in the last twelve months to 1.71M, down -46.88% year-over-year. In the year 2025, CHO Pharma had annual revenue of 1.43M, down -60.03%.
Revenue (ttm)
1.71M
Revenue Growth
-46.88%
P/S Ratio
14,058.17
Revenue / Employee
n/a
Employees
47
Market Cap
23.97B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.43M | -2.15M | -60.03% |
| Dec 31, 2024 | 3.58M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 60.00K | -3.51M | -98.32% |
| Dec 31, 2021 | 3.57M | 3.43M | 2,486.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sunmax Biotechnology | 2.04B |
| EirGenix | 1.21B |
| Ever Supreme Bio Technology | 1.08B |
| TaiMed Biologics | 619.49M |
| Medigen Vaccine Biologics | 573.85M |
| Oneness Biotech | 153.78M |
| Polaris Group | 69.27M |
| ACRO Biomedical | 52.76M |